MicroDysis, a Princeton-based biomedical instrumentation company, announces the validation of its Elim-3500 Autostainer, a patented microfluidic benchtop device designed to transform laboratory tissue slide staining. Conventional workflows can take hours, consuming large amounts of reagents, requiring intensive labor, and introducing variability. The Elim-3500 accelerates this process, delivering high-quality, reproducible H&E and IHC staining across multiple tissue types, with validation confirming up to 80% reduction in reagent use.
Built on more than a decade of microfluidics, engineering, and laboratory instrumentation, the compact platform integrates automated fluidic control, precision thermal management, and programmable protocols. It provides speed, precision, and reliability while enabling overnight unattended operation for efficiency. By reducing reagent use and minimizing repetitive labor, the system delivers rapid ROI and eases the burden on lab staff.
Looking ahead, MicroDysis is developing the Elim-4000 Autostainer for clinical application. This next-generation platform, featuring digital imaging and AI-powered recognition, aims to deliver H&E and IHC results in under 15 minutes, enabling rapid intraoperative surgical diagnosis.
With the Elim-3500 validated for research and the Elim-4000 envisioned for clinical use, MicroDysis is advancing patented technologies that promise lab automation, faster diagnoses, and lasting benefits for healthcare worldwide.